Enterovirus Radiculoneuropathy Management

Diagnostic Approach

• Diagnosis of enterovirus radiculoneuropathy relies on CSF PCR for enterovirus detection, not serum antibody testing, with results available within 24-48 hours of lumbar puncture 1, 2
• The primary diagnostic method is direct viral detection via PCR, as serum antibody testing has limited utility due to potential false negatives in immunocompromised patients and confounding by prior IVIG treatment 1, 2, 3

IVIG Treatment Considerations

• IVIG may be considered in patients with severe enterovirus neurological disease, particularly in immunosuppressed patients, despite limited evidence from controlled trials 1, 2
• The recommendation for IVIG in enterovirus radiculoneuropathy is Grade C, Level III evidence, with no placebo-controlled trials existing for enterovirus encephalitis or radiculoneuropathy 1, 2

Dosing and Administration

• Standard dosing for IVIG is 2 g/kg divided over 2-5 days 4, 5, 6
• Alternative approach: 1-2 g/kg in 2-4 divided doses 7
• Treatment may need to be repeated at monthly intervals for sustained effect 5, 6

Monitoring During Treatment

• Monitor IgG levels if hypogammaglobulinemia is present, with target IgG levels ≥400 mg/dL 3
• Assess for adverse effects: headache, aseptic meningitis, anaphylaxis, and volume overload 5, 6, 8
• Clinical neurological review should occur within 24 hours of referral 1, 2

Critical Care Considerations

• Patients with severe enterovirus radiculoneuropathy require urgent ICU assessment if consciousness is declining 1, 2
• Access to neuroimaging (MRI and CT) and neurophysiology (EEG) is necessary 1, 2
• Transfer to a specialist neuroscience unit within 24 hours if diagnosis is unclear or patient fails to improve 1, 2